Tolterodine Tartrate
Brand name: Tolterodine Tartrate Er
Rank #405 of 500 drugs by total cost
$21.8M
Total Cost
178,340
Total Claims
$21.8M
Total Cost
8,487
Prescribers
$122
Cost per Claim
13,064
Beneficiaries
282,394
30-Day Fills
$2,572
Avg Cost/Provider
21
Avg Claims/Provider
About Tolterodine Tartrate
Tolterodine Tartrate (sold as Tolterodine Tartrate Er) was prescribed 178,340 times by 8,487 Medicare Part D providers in 2023, costing the program $21.8M. At $122 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 402 | Doxepin Hcl (Doxepin Hcl) | $22.2M | 371,255 |
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
| 407 | Ondansetron (Ondansetron Odt) | $21.5M | 1,261,950 |
| 408 | Asciminib Hydrochloride (Scemblix) | $21.4M | 830 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology